“In just six months since the strategic combination that formed Walgreens Boots Alliance, we are beginning to make progress in our operations, as we were able to deliver another strong quarter”, said Mr Pessina.
Advertisement
Walgreens, which recently acquired British chain Boots, reported net earnings per diluted share for the third quarter at $1.02. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Sales during the period jumped up 48.4% to $28.8bn, helped by the addition of figures from Alliance Boots. The firm, nonetheless, raised and narrowed its outlook for the full 2015 fiscal year to a range of $3.70 to $3.80 per share for adjusted net earnings attributable to Walgreens Boots Alliance on a diluted basis. The 73-year-old Italian formerly ran the Alliance Boots chains in Europe prior to their acquisition by Walgreens. The stock has risen 13 per cent in the last 12 months.
Walgreens Boots Alliance Inc (NASDAQ:WBA) updated its FY15 earnings guidance on Thursday. CVS, +1.65% “we see potential multiple expansion as limited in the near term until management can generate meaningful growth in same-store metrics”, both on the pharmacy and front-end nonpharmacy sales, Ransom said.
On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, Lederer John Anthony, Director of Walgreens Boots Alliance, Inc., had purchased 10,000 shares on April 29, 2015. (NASDAQ:WBA) caters to the Services space. He played a key role in the union which involved Alliance Boots and Walgreen Co.
Walgreens also announced that it will buy United Kingdom skin-care and beauty brand Liz Earle from Avon Products (AVP) for $215.7 million in cash.
To boost sales and margins the company has launched a $1.5 billion cost-cutting plan, which includes freezing salary hikes for senior US executives and store closures.
The Retail Pharmacy worldwide division posted sales of $3.3 billion, with comps up 3.2%. The pharmacy operator reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.87 by $0.15.
Advertisement
The dividend, payable September 11 to stockholders of record on August 19, was raised to 36 cents a share from 33.8 cents.
